Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 21 min ago
Peer-reviewedLicence not statedTransplantation and cellular therapy

Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation

  • Matty Slaught1
  • Lynn Onstad2
  • Paul A. Carpenter2,3
  • Sioban B. Keel4
  • Catherine J. Lee2
  • Shivaprasad Manjappa2
  • Lauri Burroughs2,3
  • Rohtesh S. Mehta5
  • Masumi Ueda Oshima2
  • Phuong Vo2
  • K. Scott Baker2,3
  • Stephanie J. Lee2
1 more authors
  • Neel S. Bhatt2,3
5 affiliations
  1. 1Virginia Mason Medical Center, Seattle, WA
  2. 2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
  3. 3Department of Pediatrics, Division of Hematology/Oncology and Stem Cell Transplantation, University of Washington School of Medicine, Seattle, WA
  4. 4Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA
  5. 5Stem Cell Transplantation and Cellular Therapies, University of Texas, MD Anderson Cancer Center, Houston, TX
Read full textDOICite

Related

  1. Efficacy of Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single-Center Retrospective Study.
    Jinrong Zhao, Liangliang Wu, Ming Zhou +11
    International journal of medical sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Haploidentical hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for severe aplastic anemia patients aged 40-65: a multicenter retrospective study.
    Xiaohui Xiao, Guiping Chen, Cong Xu +11
    Annals of hematologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCDOAJ
  3. EFFICACY AND SAFETY OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AS FIRST-LINE TREATMENT FOR SEVERE APLASTIC ANEMIA IN CHILDREN: A SYSTEMATIC REVIEW
    Pedro Henrique Rodrigues VIANA, Lucas De Barros ANASTáCIO
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  4. Increased Susceptibility to Long-Term Complications in Leukemia Survivors Who Received Hematopoietic Stem Cell Transplantation During Adolescence
    Léna Pessarossi, Marilyne Poiree, Jean-Hugues Dalle +23
    Transplantation and Cellular TherapyPeer-reviewedCC BY 4.0Full text1 citedObstetrics, gynaecology & paediatricsHAL
  5. Long-term endocrine and reproductive outcomes in female adolescent and young adult survivors after hematopoietic stem cell transplantation for hematological malignancies during childhood or adolescence
    Weronika Zajączkowska, Katarzyna Derwich, Cezary Miedziarek +5
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{slaught2026comparison,
  title = {{Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation}},
  author = {Matty Slaught and Lynn Onstad and Paul A. Carpenter and Sioban B. Keel and Catherine J. Lee and Shivaprasad Manjappa and Lauri Burroughs and Rohtesh S. Mehta and Masumi Ueda Oshima and Phuong Vo and K. Scott Baker and Stephanie J. Lee and Neel S. Bhatt},
  journal = {Transplantation and cellular therapy},
  year = {2026},
  month = aug,
  doi = {10.1016/j.jtct.2026.08.036},
  url = {https://doi.org/10.1016/j.jtct.2026.08.036},
}
RIS
TY  - JOUR
TI  - Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation
AU  - Matty Slaught
AU  - Lynn Onstad
AU  - Paul A. Carpenter
AU  - Sioban B. Keel
AU  - Catherine J. Lee
AU  - Shivaprasad Manjappa
AU  - Lauri Burroughs
AU  - Rohtesh S. Mehta
AU  - Masumi Ueda Oshima
AU  - Phuong Vo
AU  - K. Scott Baker
AU  - Stephanie J. Lee
AU  - Neel S. Bhatt
PY  - 2026
DA  - 2026/08/21
JO  - Transplantation and cellular therapy
DO  - 10.1016/j.jtct.2026.08.036
UR  - https://doi.org/10.1016/j.jtct.2026.08.036
SN  - 2666-6375
SN  - 2666-6367
ER  -